Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity

Age

Volumn 35, Issue 3, 2013, Pages 993-1005

  Benigni, Ariela ^a   Orisio, Silvia ^a   Noris, Marina ^b   Iatropoulos, Paraskevas ^b   Castaldi, Davide ^c   Kamide, Kei ^d   Rakugi, Hiromi ^d   Arai, Yasumichi ^e   Todeschini, Marta ^b   Ogliari, Giulia ^f   Imai, Enyu ^g   Gondo, Yasuyuki ^d   Hirose, Nobuyoshi ^e   Mari, Daniela ^f   Remuzzi, Giuseppe ^b,h  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d OSAKA UNIVERSITY   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF MILAN   (Italy)

^g NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h OSPEDALI RIUNITI   (Italy)

Author keywords

Angiotensin II type I receptor; Centenarians; Genetic polymorphism; Human longevity

Indexed keywords

ANGIOTENSIN 1 RECEPTOR;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR GENE; ARTICLE; BLOOD PRESSURE REGULATION; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LIFE EXTENSION; LONGEVITY; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; AGING; ALLELES; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; ITALY; LINKAGE DISEQUILIBRIUM; LONGEVITY; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RETROSPECTIVE STUDIES;

EID: 84880537329     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-012-9408-8     Document Type: Article

References (38)

1. Alba G, El Bekay R, Chacon P, Reyes ME, Ramos E, Olivan J, Jimenez J, Lopez JM, Martin-Nieto J, Pintado E, Sobrino F (2008) Heme oxygenase-1 expression is down-regulated by angiotensin II and under hypertension in human neutrophils. J Leukoc Biol 84(2):397-405. doi: 10.1189/jlb.0108035
2. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265. doi: 10.1093/bioinformatics/bth457
3. Benigni A, Corna D, Zoja C, Sonzogni A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G (2009) Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest 119(3):524-530. doi: 10.1172/JCI36703
4. Benigni A, Cassis P, Remuzzi G (2010) Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med 2(7):247-257. doi: 10.1002/emmm.201000080
5. Bilal E, Rabadan R, Alexe G, Fuku N, Ueno H, Nishigaki Y, Fujita Y, Ito M, Arai Y, Hirose N, Ruckenstein A, Bhanot G, Tanaka M (2008) Mitochondrial DNA haplogroup D4a is a marker for extreme longevity in Japan. PLoS One 3(6):e2421. doi: 10.1371/journal.pone.0002421
6. Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P, Fabricio AS, Squarcina E, Gion M, Palatini P, Semplicini A (2011) Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens. doi: 10.1038/ajh.2010.211
7. Corder EH, Lannfelt L, Basun H (1996) Apolipoprotein E genotype and the rate of decline in probable Alzheimer disease. Arch Neurol 53(11):1094-1095
8. de Cavanagh EM, Inserra F, Ferder M, Ferder L (2007) From mitochondria to disease: role of the renin-angiotensin system. Am J Nephrol 27(6):545-553. doi: 10.1159/000107757
9. El Bekay R, Alvarez M, Monteseirin J, Alba G, Chacon P, Vega A, Martin-Nieto J, Jimenez J, Pintado E, Bedoya FJ, Sobrino F (2003) Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB. Blood 102(2):662-671. doi: 10.1182/blood-2002- 09-2785
10. Erdmann J, Riedel K, Rohde K, Folgmann I, Wienker T, Fleck E, Regitz-Zagrosek V (1999) Characterization of polymorphisms in the promoter of the human angiotensin II subtype 1 (AT1) receptor gene. Ann Hum Genet 63(Pt 4):369-374
11. Flachsbart F, Caliebe A, Kleindorp R, Blanche H, von Eller-Eberstein H, Nikolaus S, Schreiber S, Nebel A (2009) Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc Natl Acad Sci U S A 106(8):2700-2705. doi: 10.1073/pnas.0809594106
12. Gu D, Kelly TN, Hixson JE, Chen J, Liu D, Chen JC, Rao DC, Mu J, Ma J, Jaquish CE, Rice TK, Gu C, Hamm LL, Whelton PK, He J (2010) Genetic variants in the renin-angiotensin-aldosterone system and salt sensitivity of blood pressure. J Hypertens 28(6):1210-1220
13. Guasti L, Marino F, Cosentino M, Maio RC, Rasini E, Ferrari M, Castiglioni L, Klersy C, Gaudio G, Grandi AM, Lecchini S, Venco A (2008) Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up. Eur Heart J 29(9):1118-1126. doi: 10.1093/eurheartj/ehn138
14. Inukai T, Yoshida N, Wakabayashi S, Inukai Y, Matsutomo R, Takanashi K, Nakamachi T, Takebayashi K, Aso Y, Takahashi K (2005) Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus. Am J Med Sci 329(5):222-227
15. Jurewicz M, McDermott DH, Sechler JM, Tinckam K, Takakura A, Carpenter CB, Milford E, Abdi R (2007) Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol 18(4):1093-1102. doi: 10.1681/ASN.2006070707
16. Kumar A, Prater A, Li Y, Jain S (2005) A haplotype of the angiotensin-II receptor subtype-1 is associated with hypertension in Caucasian women. Circulation 111(4):E-52
17. Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073-1081. doi: 10.1038/nprot.2009.86
18. Marino F, Guasti L, Cosentino M, Ferrari M, Rasini E, Maio RC, Cimpanelli MG, Cereda E, Crespi C, Simoni C, Restelli D, Venco A, Lecchini S (2007) Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. J Cardiovasc Pharmacol 49(5):299-305. doi: 10.1097/FJC.0b013e31803d35ce
19. Marino F, Guasti L, Tozzi M, Consuelo Maio R, Castiglioni L, Rasini E, Schembri L, Maroni L, Legnaro M, De Leo A, Piffaretti G, Castelli P, Venco A, Lecchini S, Cosentino M (2009) Angiotensin type 1 receptor expression and interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral arterial disease. J Cardiovasc Pharmacol 54(6):520-525. doi: 10.1097/FJC.0b013e3181bfadfd
20. Martinez-Rodriguez N, Posadas-Romero C, Cardoso G, Rodriguez-Perez JM, Perez-Hernandez N, Vallejo M, Vargas Alarcon G (2011) Association of angiotensin II type 1-receptor gene polymorphisms with the risk of developing hypertension in Mexican individuals. J Renin Angiotensin Aldosterone Syst. doi: 10.1177/1470320311419175
21. Min LJ, Mogi M, Iwai M, Horiuchi M (2009) Signaling mechanisms of angiotensin II in regulating vascular senescence. Ageing Res Rev 8(2):113-121. doi: 10.1016/j.arr.2008.12.002
22. Mottl AK, Shoham DA, North KE (2008) Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review. Genet Med 10(8):560-574. doi: 10.1097/GIM.0b013e3181809613
23. Ng PC, Henikoff S (2002) Accounting for human polymorphisms predicted to affect protein function. Genome Res 12(3):436-446. doi: 10.1101/gr.212802
24. Nikiforovich GV, Zhang M, Yang Q, Jagadeesh G, Chen HC, Hunyady L, Marshall GR, Catt KJ (2006) Interactions between conserved residues in transmembrane helices 2 and 7 during angiotensin AT1 receptor activation. Chem Biol Drug Des 68(5):239-249. doi: 10.1111/j.1747-0285.2006.00444.x
25. Noris M, Ruggenenti P, Todeschini M, Figliuzzi M, Macconi D, Zoja C, Paris S, Gaspari F, Remuzzi G (1996) Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injury. Am J Kidney Dis 27(6):790-796
26. Noris M, Azzollini N, Mister M, Pezzotta A, Piccinini G, Casiraghi F, Cugini D, Perico N, Orisio S, Remuzzi G (1999) Peripheral donor leukocytes prolong survival of rat renal allografts. Kidney Int 56(3):1101-1112. doi: 10.1046/j.1523-1755.1999.00631.x
27. Oliverio MI, Kim HS, Ito M, Le T, Audoly L, Best CF, Hiller S, Kluckman K, Maeda N, Smithies O, Coffman TM (1998) Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A 95(26):15496-15501
28. Palatini P, Ceolotto G, Dorigatti F, Mos L, Santonastaso M, Bratti P, Papparella I, Pessina AC, Semplicini A (2009) Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome. Am J Hypertens 22(2):208-214. doi: 10.1038/ajh.2008.319
29. Paragh G, Szabo J, Kovacs E, Keresztes T, Karpati I, Balogh Z, Pall D, Foris G (2002) Altered signal pathway in angiotensin II-stimulated neutrophils of patients with hypercholesterolaemia. Cell Signal 14(9):787-792
30. Pawlikowska L, Hu D, Huntsman S, Sung A, Chu C, Chen J, Joyner AH, Schork NJ, Hsueh WC, Reiner AP, Psaty BM, Atzmon G, Barzilai N, Cummings SR, Browner WS, Kwok PY, Ziv E (2009) Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell 8(4):460-472. doi: 10.1111/j.1474-9726.2009.00493.x
31. Rasini E, Cosentino M, Marino F, Legnaro M, Ferrari M, Guasti L, Venco A, Lecchini S (2006) Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. Regul Pept 134(2-3):69-74. doi: 10.1016/j.regpep.2006.01.007
32. Rosenbaum DM, Rasmussen SG, Kobilka BK (2009) The structure and function of G-protein-coupled receptors. Nature 459(7245):356-363. doi: 10.1038/nature08144
33. Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, Antonarakis SE (2007) Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet 81(2):405-413. doi: 10.1086/519979
34. Sirtori CR, Calabresi L, Franceschini G, Baldassarre D, Amato M, Johansson J, Salvetti M, Monteduro C, Zulli R, Muiesan ML, Agabiti-Rosei E (2001) Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study. Circulation 103(15):1949-1954
35. Sunyaev S, Ramensky V, Koch I, Lathe W 3rd, Kondrashov AS, Bork P (2001) Prediction of deleterious human alleles. Hum Mol Genet 10(6):591-597
36. Willcox BJ, Donlon TA, He Q, Chen R, Grove JS, Yano K, Masaki KH, Willcox DC, Rodriguez B, Curb JD (2008) FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A 105(37):13987-13992. doi: 10.1073/pnas.0801030105
37. Wilson SK (1990) Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rat. Circ Res 66(3):722-734
38. Zamar D, Brad McNemey, Graham J (2007) elrm: software implementing exact-like inference for logistic regression models. J Stat Softw 21(3)